{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:03:11Z","timestamp":1791450191940,"version":"4.3.3"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1185454"],"award-info":[{"award-number":["OPP1185454"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.contraception.2023.109953","type":"journal-article","created":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T10:57:53Z","timestamp":1673434673000},"page":"109953","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Real-world effect of a potential drug-drug interaction between topiramate and oral contraceptives on unintended pregnancy outcomes"],"prefix":"10.1016","volume":"120","author":[{"given":"Amir","family":"Sarayani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almut","family":"Winterstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Cristofoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valva","family":"Vozmediano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2023.109953_bib0001","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003026","article-title":"Estimating progress towards meeting women's contraceptive needs in 185 countries: a Bayesian hierarchical modelling study","volume":"17","author":"Kantorov\u00e1","year":"2020","journal-title":"PLOS Medicine"},{"key":"10.1016\/j.contraception.2023.109953_bib0002","unstructured":"Contraceptive Use by Method 2019 - Data Booklet. United Nations, Department of Economic and Social Affairs; 2019."},{"key":"10.1016\/j.contraception.2023.109953_bib0003","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.contraception.2012.07.016","article-title":"Burden of unintended pregnancy in the United States: potential savings with increased use of long-acting reversible contraception","volume":"87","author":"Trussell","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2023.109953_bib0004","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2165\/00003088-200038040-00004","article-title":"Pharmacokinetic drug interactions between oral contraceptives and second-generation anticonvulsants","volume":"38","author":"Wilbur","year":"2000","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.contraception.2023.109953_bib0005","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.contraception.2016.08.003","article-title":"Clarification of contraceptive drug pharmacokinetics in obesity","volume":"95","author":"Jusko","year":"2017","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2023.109953_bib0006","series-title":"Endotext - Endocrinology of Female Reproduction","article-title":"Contraception","author":"Horvath","year":"2018"},{"key":"10.1016\/j.contraception.2023.109953_bib0007","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/cts.12499","article-title":"Role of CYP3A in Oral Contraceptives Clearance","volume":"11","author":"Zhang","year":"2018","journal-title":"Clin Transl Sci"},{"issue":"2","key":"10.1016\/j.contraception.2023.109953_bib0008","first-page":"S49","article-title":"Drug-drug interaction studies with oral contraceptives: pharmacokinetic\/pharmacodynamic and study design considerations","volume":"60","author":"Sun","year":"2020","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.contraception.2023.109953_bib0009","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/head.13157","article-title":"Migraine prophylaxis and acute treatment patterns among commercially insured patients in the United States","volume":"57","author":"Woolley","year":"2017","journal-title":"Headache"},{"key":"10.1016\/j.contraception.2023.109953_bib0010","doi-asserted-by":"crossref","first-page":"e342","DOI":"10.1212\/WNL.0000000000004857","article-title":"Topiramate use early in pregnancy and the risk of oral clefts: A pregnancy cohort study","volume":"90","author":"Hernandez-Diaz","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.contraception.2023.109953_bib0011","unstructured":"U.S. Food and Drug Administration. Full Prescribing Information. Topamax (topiramate). https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/020844s041lbl.pdf. Access date June 15, 2022."},{"key":"10.1016\/j.contraception.2023.109953_bib0012","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1046\/j.1528-1157.2003.55602.x","article-title":"Effect of topiramate or carbamazepine on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and nonobese female subjects","volume":"44","author":"Doose","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.contraception.2023.109953_bib0013","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1528-1157.1997.tb01123.x","article-title":"Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy","volume":"38","author":"Rosenfeld","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.contraception.2023.109953_bib0014","unstructured":"Centers for Disease Control and Prevention. National Center for Chronic Disease Prevention and Health Promotion. Summary Chart of U.S. Medical Eligibility Criteria for Contraceptive Use. https:\/\/www.cdc.gov\/reproductivehealth\/contraception\/pdf\/summary-chart-us-medical-eligibility-criteria_508tagged.pdf. Access date June 15, 2022."},{"key":"10.1016\/j.contraception.2023.109953_bib0015","article-title":"A pharmacoepidemiologic approach to evaluate real-world effectiveness of hormonal contraceptives in the presence of drug-drug interactions","author":"Sarayani","year":"2020","journal-title":"Epidemiology"},{"key":"10.1016\/j.contraception.2023.109953_bib0016","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.2147\/CLEP.S269400","article-title":"Impact of the transition from ICD\u20139\u2013CM to ICD\u201310\u2013CM on the identification of pregnancy episodes in US health insurance claims data","volume":"12","author":"Sarayani","year":"2020","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.contraception.2023.109953_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192033","article-title":"Inferring pregnancy episodes and outcomes within a network of observational databases","volume":"13","author":"Matcho","year":"2018","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.contraception.2023.109953_bib0018","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/pds.5126","article-title":"Validation of algorithms to estimate gestational age at birth in the Medicaid Analytic eXtract\u2014Quantifying the misclassification of maternal drug exposure during pregnancy","volume":"29","author":"Zhu","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.contraception.2023.109953_bib0019","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/EDE.0b013e3181a663cc","article-title":"High-dimensional propensity score adjustment in studies of treatment effects using health care claims data","volume":"20","author":"Schneeweiss","year":"2009","journal-title":"Epidemiology"},{"key":"10.1016\/j.contraception.2023.109953_bib0020","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/j.0013-9580.2003.06203.x","article-title":"Dose-dependent induction of cytochrome P450 (CYP) 3A4 and activation of pregnane X receptor by topiramate","volume":"44","author":"Nallani","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.contraception.2023.109953_bib0021","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/rheumatology\/kez320","article-title":"Methodological considerations when analysing and interpreting real-world data","volume":"59","author":"St\u00fcrmer","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.contraception.2023.109953_bib0022","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/pds.4789","article-title":"Use of real-world evidence from healthcare utilization data to evaluate drug safety during pregnancy","volume":"28","author":"Huybrechts","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.contraception.2023.109953_bib0023","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/j.1475-6773.2006.00635.x","article-title":"Development of an algorithm to identify pregnancy episodes in an integrated health care delivery system","volume":"42","author":"Hornbrook","year":"2007","journal-title":"Health Serv Res"},{"key":"10.1016\/j.contraception.2023.109953_bib0024","first-page":"286","article-title":"Oral contraceptive failures in the presence of a drug-drug interaction \u2013 does progestin type matter?","volume":"1","author":"Sarayani","year":"2021","journal-title":"Pharm Epi Drug Safety"},{"key":"10.1016\/j.contraception.2023.109953_bib0025","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.contraception.2020.12.002","article-title":"Comparison of contraceptive failures associated with CYP3A4-inducing drug-drug interactions by route of hormonal contraceptive in an adverse event reporting system","volume":"103","author":"Sunaga","year":"2021","journal-title":"Contraception"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782423000069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782423000069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T20:22:07Z","timestamp":1757881327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782423000069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":25,"alternative-id":["S0010782423000069"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2023.109953","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world effect of a potential drug-drug interaction between topiramate and oral contraceptives on unintended pregnancy outcomes","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2023.109953","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109953"}}